11/14/2025
Semax, a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), derived from adrenocorticotropic hormone (ACTH), has emerged as a subject of growing interest in various scientific domains, particularly within neurobiological and molecular research. Originally synthesized in Russia, Semax was designed to retain some of the regulatory properties of ACTH without interacting with glucocorticoid receptors. This structural alteration has directed attention to the peptide's unique molecular architecture and its potential in modulating neurological, genetic, and cellular processes across a variety of research models....
Semax, a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), derived from adrenocorticotropic hormone (ACTH), has emerged as a subject of growing interest in various scientific domains, particula…